Scientists from the University of Sharjah think monoclonal antibodies hold the potential to be a far better treatment for ...

A study led by Dr. Hassan Aboul-Ella (Department of Microbiology, Faculty of Veterinary Medicine, Cairo University) has been ...

Recent advancements in monoclonal antibody engineering are reshaping disease treatment, focusing on safety, effectiveness, and addressing current medical needs.

Explore how mAbs are transforming disease treatment, the evolution from murine to humanized antibodies, and the impact of biosimilar antibodies on cost-effective therapies.

Avantor, Inc. (NYSE: AVTR) has announced an expanded partnership with the National Institute for Bioprocessing Research and ...

In a review paper published in Molecular Biomedicine, an international team of scientists comprehensively: (1) highlight the fundamentals of mAbs-development and optimization technologies, (2) focus ...

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO ...

Identifying reliable operational parameters as early as possible in the development process can significantly streamline ...

Figure 2 depicts the impact of pH on monoclonal antibody stability ... information from initial development to downstream production and processing. Figure 3 shows the superimposition of the ...

It is essential to increase the number of autonomous agents in bioprocess development for biopharma innovation.